Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $300069.0.

  • Onconetix's Interest Expenses rose 2953.22% to $300069.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $995107.0, marking a year-over-year increase of 2235.02%. This contributed to the annual value of $873433.0 for FY2024, which is 3004.77% up from last year.
  • Per Onconetix's latest filing, its Interest Expenses stood at $300069.0 for Q3 2025, which was up 2953.22% from $223097.0 recorded in Q2 2025.
  • Onconetix's 5-year Interest Expenses high stood at $300069.0 for Q3 2025, and its period low was $187993.0 during Q1 2024.
  • Over the past 3 years, Onconetix's median Interest Expenses value was $223344.5 (recorded in 2025), while the average stood at $229152.7.
  • Over the last 5 years, Onconetix's Interest Expenses had its largest YoY gain of 3172.78% in 2024, and its largest YoY loss of 1391.36% in 2024.
  • Over the past 3 years, Onconetix's Interest Expenses (Quarter) stood at $188532.0 in 2023, then skyrocketed by 31.73% to $248349.0 in 2024, then grew by 20.83% to $300069.0 in 2025.
  • Its last three reported values are $300069.0 in Q3 2025, $223097.0 for Q2 2025, and $223592.0 during Q1 2025.